# BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

> **NCT05004038** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 60 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** BCG Vaccine AJVaccines

## Key facts

- **NCT ID:** NCT05004038
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05004038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05004038, "BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05004038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*